Global Biosimilars Market Professional Survey Report 2021

Report Description


The Global Biosimilars Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Biosimilars Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Biosimilars Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Biosimilars Market product affairs. The report is at risk of project regarding this Biosimilars Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Pfizer
  • Sandoz International GmbH
  • Teva Pharmaceuticals Industries
  • Amgen Inc
  • Biocon
  • Dr. Reddys Laboratories
  • F. Hoffmann-La Roche
  • Celltrion
  • Samsung Bioepis

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Biosimilars related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Biosimilars Market

Biosimilars Market

Report Highlights:


The Biosimilars Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Biosimilars Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Biosimilars Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Biosimilars Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Biosimilars marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Biosimilars market using a bottom-up approach, wherein manufacturers value data for different type (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin), Peptides (Glucagon, Calcitonin)), of Biosimilars market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Biosimilars Market

Biosimilars Market

Key Target Audience:


  • Biosimilars market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Biosimilars market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Biosimilars market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Biosimilars market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Recombinant Non-glycosylated Proteins (Insulin
  • rHGH
  • Interferon)
  • Glycosylated (mAb
  • EPO)
  • Peptides (Glucagon
  • Calcitonin)
  • Peptides (Glucagon
  • Calcitonin)

By end-user also classify into, the Global Biosimilars market:


Global Biosimilars market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Oncology
  • Blood Disorders

Highlights of this 2021-2027 Biosimilars Market Report:

  • Market dynamics, Biosimilars economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Biosimilars industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Biosimilars Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Biosimilars businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Biosimilars market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents

Executive Summary
1 Industry Overview of Biosimilars
1.1 Definition of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.4 Peptides (Glucagon, Calcitonin)
1.3 Biosimilars Segment by Applications
1.3.1 Global Biosimilars Consumption Comparison by Applications (2016-2027)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Global Biosimilars Overall Market
1.4.1 Global Biosimilars Revenue (2016-2027)
1.4.2 Global Biosimilars Production (2016-2027)
1.4.3 North America Biosimilars Status and Prospect (2016-2027)
1.4.4 Europe Biosimilars Status and Prospect (2016-2027)
1.4.5 China Biosimilars Status and Prospect (2016-2027)
1.4.6 Japan Biosimilars Status and Prospect (2016-2027)
1.4.7 Southeast Asia Biosimilars Status and Prospect (2016-2027)
1.4.8 India Biosimilars Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars
2.3 Manufacturing Process Analysis of Biosimilars
2.4 Industry Chain Structure of Biosimilars

3 Development and Manufacturing Plants Analysis of Biosimilars
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilars Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilars
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Biosimilars Production and Capacity Analysis
4.2 Biosimilars Revenue Analysis
4.3 Biosimilars Price Analysis
4.4 Market Concentration Degree

5 Biosimilars Regional Market Analysis
5.1 Biosimilars Production by Regions
5.1.1 Global Biosimilars Production by Regions
5.1.2 Global Biosimilars Revenue by Regions
5.2 Biosimilars Consumption by Regions
5.3 North America Biosimilars Market Analysis
5.3.1 North America Biosimilars Production
5.3.2 North America Biosimilars Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilars Import and Export
5.4 Europe Biosimilars Market Analysis
5.4.1 Europe Biosimilars Production
5.4.2 Europe Biosimilars Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilars Import and Export
5.5 China Biosimilars Market Analysis
5.5.1 China Biosimilars Production
5.5.2 China Biosimilars Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilars Import and Export
5.6 Japan Biosimilars Market Analysis
5.6.1 Japan Biosimilars Production
5.6.2 Japan Biosimilars Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilars Import and Export
5.7 Southeast Asia Biosimilars Market Analysis
5.7.1 Southeast Asia Biosimilars Production
5.7.2 Southeast Asia Biosimilars Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilars Import and Export
5.8 India Biosimilars Market Analysis
5.8.1 India Biosimilars Production
5.8.2 India Biosimilars Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilars Import and Export

6 Biosimilars Segment Market Analysis (by Type)
6.1 Global Biosimilars Production by Type
6.2 Global Biosimilars Revenue by Type
6.3 Biosimilars Price by Type

7 Biosimilars Segment Market Analysis (by Application)
7.1 Global Biosimilars Consumption by Application
7.2 Global Biosimilars Consumption Market Share by Application (2016-2021)

8 Biosimilars Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Biosimilars Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Sandoz International GmbH
8.2.1 Sandoz International GmbH Biosimilars Production Sites and Area Served
8.2.2 Sandoz International GmbH Product Introduction, Application and Specification
8.2.3 Sandoz International GmbH Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceuticals Industries
8.3.1 Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
8.3.2 Teva Pharmaceuticals Industries Product Introduction, Application and Specification
8.3.3 Teva Pharmaceuticals Industries Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 Amgen Inc
8.4.1 Amgen Inc Biosimilars Production Sites and Area Served
8.4.2 Amgen Inc Product Introduction, Application and Specification
8.4.3 Amgen Inc Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Biocon
8.5.1 Biocon Biosimilars Production Sites and Area Served
8.5.2 Biocon Product Introduction, Application and Specification
8.5.3 Biocon Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Dr. Reddys Laboratories
8.6.1 Dr. Reddys Laboratories Biosimilars Production Sites and Area Served
8.6.2 Dr. Reddys Laboratories Product Introduction, Application and Specification
8.6.3 Dr. Reddys Laboratories Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche
8.7.1 F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Celltrion
8.8.1 Celltrion Biosimilars Production Sites and Area Served
8.8.2 Celltrion Product Introduction, Application and Specification
8.8.3 Celltrion Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 Samsung Bioepis
8.9.1 Samsung Bioepis Biosimilars Production Sites and Area Served
8.9.2 Samsung Bioepis Product Introduction, Application and Specification
8.9.3 Samsung Bioepis Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Biosimilars Market
9.1 Global Biosimilars Market Trend Analysis
9.1.1 Global Biosimilars Market Size (Volume and Value) Forecast 2021-2027
9.2 Biosimilars Regional Market Trend
9.2.1 North America Biosimilars Forecast 2021-2027
9.2.2 Europe Biosimilars Forecast 2021-2027
9.2.3 China Biosimilars Forecast 2021-2027
9.2.4 Japan Biosimilars Forecast 2021-2027
9.2.5 Southeast Asia Biosimilars Forecast 2021-2027
9.2.6 India Biosimilars Forecast 2021-2027
9.3 Biosimilars Market Trend (Product Type)
9.4 Biosimilars Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilars Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Biosimilars
Table Global Biosimilars Production (K MT) Growth Rate Comparison by Types (2016-2027)
Figure Global Biosimilars Production Market Share by Types in 2020
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure Peptides (Glucagon, Calcitonin) Product Picture
Table Global Biosimilars Consumption (K MT) Comparison by Applications (2016-2027)
Figure Global Biosimilars Consumption Market Share by Applications in 2020
Figure Oncology
Figure Blood Disorders
Figure Global Biosimilars Revenue (Million USD) (2016-2027)
Figure Global Biosimilars Production (K MT) (2016-2027)
Figure North America Biosimilars Market Size (Million USD) (2016-2027)
Figure Europe Biosimilars Market Size (Million USD) (2016-2027)
Figure China Biosimilars Market Size (Million USD) (2016-2027)
Figure Japan Biosimilars Market Size (Million USD) (2016-2027)
Figure Southeast Asia Biosimilars Market Size (Million USD) (2016-2027)
Figure India Biosimilars Market Size (Million USD) (2016-2027)
Table Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars in 2020
Figure Manufacturing Process Analysis of Biosimilars
Figure Industry Chain Structure of Biosimilars
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilars Manufacturing Plants Distribution
Table Biosimilars Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilars Capacity (K MT) of Major Manufacturers (2016-2021)
Table Biosimilars Production (K MT) of Major Manufacturers (2016-2021)
Table Biosimilars Production Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars Production Share by Manufacturers in 2020
Table Biosimilars Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Biosimilars Revenue Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars Revenue Share by Manufacturers in 2020
Table Biosimilars Average Price (USD/MT) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilars Production by Regions 2016-2021 (K MT)
Table Global Biosimilars Production Market Share by Regions 2016-2021
Figure Global Biosimilars Production Market Share by Regions in 2020
Table Global Biosimilars Revenue by Regions 2016-2021 (Million USD)
Table Global Biosimilars Revenue Market Share by Regions 2016-2021
Figure Global Biosimilars Revenue Market Share by Regions in 2020
Table Global Biosimilars Consumption by Regions 2016-2021 (K MT)
Table Global Biosimilars Consumption Market Share by Regions 2016-2021
Figure North America Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure North America Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table North America Biosimilars Production, Consumption Import and Export (K MT)
Figure Europe Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Europe Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Biosimilars Production, Consumption Import and Export (K MT)
Figure China Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure China Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table China Biosimilars Production, Consumption Import and Export (K MT)
Figure Japan Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Japan Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Biosimilars Production, Consumption Import and Export (K MT)
Figure Southeast Asia Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Biosimilars Production, Consumption Import and Export (K MT)
Figure India Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure India Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table India Biosimilars Production, Consumption Import and Export (K MT)
Figure Global Consumption Biosimilars Market Share by Application (2016-2021)
Figure Global Value (Consumption) Biosimilars Market Share by Application (2016-2021)
Table Pfizer Biosimilars Production Sites and Area Served
Table Pfizer Biosimilars Product Introduction, Application and Specification
Table Pfizer Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Pfizer Biosimilars Production Growth Rate (2016-2021)
Table Pfizer Biosimilars Production Market Share (2016-2021)
Figure Pfizer Biosimilars Revenue Market Share (2016-2021)
Table Pfizer Biosimilars Main Business and Markets Served
Table Sandoz International GmbH Biosimilars Production Sites and Area Served
Table Sandoz International GmbH Biosimilars Product Introduction, Application and Specification
Table Sandoz International GmbH Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Sandoz International GmbH Biosimilars Production Growth Rate (2016-2021)
Table Sandoz International GmbH Biosimilars Production Market Share (2016-2021)
Figure Sandoz International GmbH Biosimilars Revenue Market Share (2016-2021)
Table Sandoz International GmbH Biosimilars Main Business and Markets Served
Table Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
Table Teva Pharmaceuticals Industries Biosimilars Product Introduction, Application and Specification
Table Teva Pharmaceuticals Industries Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Production Growth Rate (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Production Market Share (2016-2021)
Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Main Business and Markets Served
Table Amgen Inc Biosimilars Production Sites and Area Served
Table Amgen Inc Biosimilars Product Introduction, Application and Specification
Table Amgen Inc Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Amgen Inc Biosimilars Production Growth Rate (2016-2021)
Table Amgen Inc Biosimilars Production Market Share (2016-2021)
Figure Amgen Inc Biosimilars Revenue Market Share (2016-2021)
Table Amgen Inc Biosimilars Main Business and Markets Served
Table Biocon Biosimilars Production Sites and Area Served
Table Biocon Biosimilars Product Introduction, Application and Specification
Table Biocon Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Biocon Biosimilars Production Growth Rate (2016-2021)
Table Biocon Biosimilars Production Market Share (2016-2021)
Figure Biocon Biosimilars Revenue Market Share (2016-2021)
Table Biocon Biosimilars Main Business and Markets Served
Table Dr. Reddys Laboratories Biosimilars Production Sites and Area Served
Table Dr. Reddys Laboratories Biosimilars Product Introduction, Application and Specification
Table Dr. Reddys Laboratories Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Production Growth Rate (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Production Market Share (2016-2021)
Figure Dr. Reddys Laboratories Biosimilars Revenue Market Share (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Main Business and Markets Served
Table F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
Table F. Hoffmann-La Roche Biosimilars Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Production Growth Rate (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Production Market Share (2016-2021)
Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Main Business and Markets Served
Table Celltrion Biosimilars Production Sites and Area Served
Table Celltrion Biosimilars Product Introduction, Application and Specification
Table Celltrion Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Celltrion Biosimilars Production Growth Rate (2016-2021)
Table Celltrion Biosimilars Production Market Share (2016-2021)
Figure Celltrion Biosimilars Revenue Market Share (2016-2021)
Table Celltrion Biosimilars Main Business and Markets Served
Table Samsung Bioepis Biosimilars Production Sites and Area Served
Table Samsung Bioepis Biosimilars Product Introduction, Application and Specification
Table Samsung Bioepis Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Samsung Bioepis Biosimilars Production Growth Rate (2016-2021)
Table Samsung Bioepis Biosimilars Production Market Share (2016-2021)
Figure Samsung Bioepis Biosimilars Revenue Market Share (2016-2021)
Table Samsung Bioepis Biosimilars Main Business and Markets Served
Figure Global Biosimilars Production (K MT) Growth Rate Forecast 2021-2027
Figure Global Biosimilars Revenue (Million USD) Growth Rate Forecast 2021-2027
Figure Global Biosimilars Sales Price (USD/MT) Forecast 2021-2027
Figure North America Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure North America Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Europe Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Europe Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure China Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure China Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Japan Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Japan Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Southeast Asia Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure India Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure India Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Table Global Production (K MT) of Biosimilars by Type (2021-2027)
Table Global Consumption (K MT) of Biosimilars by Application (2021-2027)
Table Biosimilars Distributors List
Table Biosimilars Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Biosimilars Market Segments


Biosimilars Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Recombinant Non-glycosylated Proteins (Insulin
  • rHGH
  • Interferon)
  • Glycosylated (mAb
  • EPO)
  • Peptides (Glucagon
  • Calcitonin)
  • Peptides (Glucagon
  • Calcitonin)

Biosimilars Application Outlook (Revenue, USD Million, 2021 2027)


  • Oncology
  • Blood Disorders

Biosimilars Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Europe
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Asia Pacific
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Latin America
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Middle East & Africa
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Biosimilars Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Biosimilars Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Biosimilars Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Biosimilars Market product affairs. The report is at risk of project regarding this Biosimilars Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Pfizer
  • Sandoz International GmbH
  • Teva Pharmaceuticals Industries
  • Amgen Inc
  • Biocon
  • Dr. Reddys Laboratories
  • F. Hoffmann-La Roche
  • Celltrion
  • Samsung Bioepis

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Biosimilars related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Biosimilars Market

Biosimilars Market

Report Highlights:


The Biosimilars Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Biosimilars Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Biosimilars Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Biosimilars Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Biosimilars marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Biosimilars market using a bottom-up approach, wherein manufacturers value data for different type (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin), Peptides (Glucagon, Calcitonin)), of Biosimilars market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Biosimilars Market

Biosimilars Market

Key Target Audience:


  • Biosimilars market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Biosimilars market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Biosimilars market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Biosimilars market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Recombinant Non-glycosylated Proteins (Insulin
  • rHGH
  • Interferon)
  • Glycosylated (mAb
  • EPO)
  • Peptides (Glucagon
  • Calcitonin)
  • Peptides (Glucagon
  • Calcitonin)

By end-user also classify into, the Global Biosimilars market:


Global Biosimilars market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Oncology
  • Blood Disorders

Highlights of this 2021-2027 Biosimilars Market Report:

  • Market dynamics, Biosimilars economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Biosimilars industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Biosimilars Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Biosimilars businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Biosimilars market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents

Executive Summary
1 Industry Overview of Biosimilars
1.1 Definition of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.4 Peptides (Glucagon, Calcitonin)
1.3 Biosimilars Segment by Applications
1.3.1 Global Biosimilars Consumption Comparison by Applications (2016-2027)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Global Biosimilars Overall Market
1.4.1 Global Biosimilars Revenue (2016-2027)
1.4.2 Global Biosimilars Production (2016-2027)
1.4.3 North America Biosimilars Status and Prospect (2016-2027)
1.4.4 Europe Biosimilars Status and Prospect (2016-2027)
1.4.5 China Biosimilars Status and Prospect (2016-2027)
1.4.6 Japan Biosimilars Status and Prospect (2016-2027)
1.4.7 Southeast Asia Biosimilars Status and Prospect (2016-2027)
1.4.8 India Biosimilars Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars
2.3 Manufacturing Process Analysis of Biosimilars
2.4 Industry Chain Structure of Biosimilars

3 Development and Manufacturing Plants Analysis of Biosimilars
3.1 Capacity and Commercial Production Date
3.2 Global Biosimilars Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Biosimilars
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Biosimilars Production and Capacity Analysis
4.2 Biosimilars Revenue Analysis
4.3 Biosimilars Price Analysis
4.4 Market Concentration Degree

5 Biosimilars Regional Market Analysis
5.1 Biosimilars Production by Regions
5.1.1 Global Biosimilars Production by Regions
5.1.2 Global Biosimilars Revenue by Regions
5.2 Biosimilars Consumption by Regions
5.3 North America Biosimilars Market Analysis
5.3.1 North America Biosimilars Production
5.3.2 North America Biosimilars Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Biosimilars Import and Export
5.4 Europe Biosimilars Market Analysis
5.4.1 Europe Biosimilars Production
5.4.2 Europe Biosimilars Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Biosimilars Import and Export
5.5 China Biosimilars Market Analysis
5.5.1 China Biosimilars Production
5.5.2 China Biosimilars Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Biosimilars Import and Export
5.6 Japan Biosimilars Market Analysis
5.6.1 Japan Biosimilars Production
5.6.2 Japan Biosimilars Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Biosimilars Import and Export
5.7 Southeast Asia Biosimilars Market Analysis
5.7.1 Southeast Asia Biosimilars Production
5.7.2 Southeast Asia Biosimilars Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Biosimilars Import and Export
5.8 India Biosimilars Market Analysis
5.8.1 India Biosimilars Production
5.8.2 India Biosimilars Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Biosimilars Import and Export

6 Biosimilars Segment Market Analysis (by Type)
6.1 Global Biosimilars Production by Type
6.2 Global Biosimilars Revenue by Type
6.3 Biosimilars Price by Type

7 Biosimilars Segment Market Analysis (by Application)
7.1 Global Biosimilars Consumption by Application
7.2 Global Biosimilars Consumption Market Share by Application (2016-2021)

8 Biosimilars Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Biosimilars Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Sandoz International GmbH
8.2.1 Sandoz International GmbH Biosimilars Production Sites and Area Served
8.2.2 Sandoz International GmbH Product Introduction, Application and Specification
8.2.3 Sandoz International GmbH Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceuticals Industries
8.3.1 Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
8.3.2 Teva Pharmaceuticals Industries Product Introduction, Application and Specification
8.3.3 Teva Pharmaceuticals Industries Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 Amgen Inc
8.4.1 Amgen Inc Biosimilars Production Sites and Area Served
8.4.2 Amgen Inc Product Introduction, Application and Specification
8.4.3 Amgen Inc Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Biocon
8.5.1 Biocon Biosimilars Production Sites and Area Served
8.5.2 Biocon Product Introduction, Application and Specification
8.5.3 Biocon Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Dr. Reddys Laboratories
8.6.1 Dr. Reddys Laboratories Biosimilars Production Sites and Area Served
8.6.2 Dr. Reddys Laboratories Product Introduction, Application and Specification
8.6.3 Dr. Reddys Laboratories Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche
8.7.1 F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Celltrion
8.8.1 Celltrion Biosimilars Production Sites and Area Served
8.8.2 Celltrion Product Introduction, Application and Specification
8.8.3 Celltrion Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 Samsung Bioepis
8.9.1 Samsung Bioepis Biosimilars Production Sites and Area Served
8.9.2 Samsung Bioepis Product Introduction, Application and Specification
8.9.3 Samsung Bioepis Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Biosimilars Market
9.1 Global Biosimilars Market Trend Analysis
9.1.1 Global Biosimilars Market Size (Volume and Value) Forecast 2021-2027
9.2 Biosimilars Regional Market Trend
9.2.1 North America Biosimilars Forecast 2021-2027
9.2.2 Europe Biosimilars Forecast 2021-2027
9.2.3 China Biosimilars Forecast 2021-2027
9.2.4 Japan Biosimilars Forecast 2021-2027
9.2.5 Southeast Asia Biosimilars Forecast 2021-2027
9.2.6 India Biosimilars Forecast 2021-2027
9.3 Biosimilars Market Trend (Product Type)
9.4 Biosimilars Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Biosimilars Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Biosimilars Market Segments


Biosimilars Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Recombinant Non-glycosylated Proteins (Insulin
  • rHGH
  • Interferon)
  • Glycosylated (mAb
  • EPO)
  • Peptides (Glucagon
  • Calcitonin)
  • Peptides (Glucagon
  • Calcitonin)

Biosimilars Application Outlook (Revenue, USD Million, 2021 2027)


  • Oncology
  • Blood Disorders

Biosimilars Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Europe
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Asia Pacific
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Latin America
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

  • Middle East & Africa
    • Biosimilars market, By Product Type Outlook
      • Recombinant Non-glycosylated Proteins (Insulin
      • rHGH
      • Interferon)
      • Glycosylated (mAb
      • EPO)
      • Peptides (Glucagon
      • Calcitonin)
      • Peptides (Glucagon
      • Calcitonin)

    • Biosimilars market, By Application Outlook
      • Oncology
      • Blood Disorders

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables and Figures
Figure Picture of Biosimilars
Table Global Biosimilars Production (K MT) Growth Rate Comparison by Types (2016-2027)
Figure Global Biosimilars Production Market Share by Types in 2020
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure Peptides (Glucagon, Calcitonin) Product Picture
Table Global Biosimilars Consumption (K MT) Comparison by Applications (2016-2027)
Figure Global Biosimilars Consumption Market Share by Applications in 2020
Figure Oncology
Figure Blood Disorders
Figure Global Biosimilars Revenue (Million USD) (2016-2027)
Figure Global Biosimilars Production (K MT) (2016-2027)
Figure North America Biosimilars Market Size (Million USD) (2016-2027)
Figure Europe Biosimilars Market Size (Million USD) (2016-2027)
Figure China Biosimilars Market Size (Million USD) (2016-2027)
Figure Japan Biosimilars Market Size (Million USD) (2016-2027)
Figure Southeast Asia Biosimilars Market Size (Million USD) (2016-2027)
Figure India Biosimilars Market Size (Million USD) (2016-2027)
Table Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars in 2020
Figure Manufacturing Process Analysis of Biosimilars
Figure Industry Chain Structure of Biosimilars
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Biosimilars Manufacturing Plants Distribution
Table Biosimilars Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Biosimilars Capacity (K MT) of Major Manufacturers (2016-2021)
Table Biosimilars Production (K MT) of Major Manufacturers (2016-2021)
Table Biosimilars Production Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars Production Share by Manufacturers in 2020
Table Biosimilars Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Biosimilars Revenue Market Share of Major Manufacturers (2016-2021)
Figure Biosimilars Revenue Share by Manufacturers in 2020
Table Biosimilars Average Price (USD/MT) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Biosimilars Production by Regions 2016-2021 (K MT)
Table Global Biosimilars Production Market Share by Regions 2016-2021
Figure Global Biosimilars Production Market Share by Regions in 2020
Table Global Biosimilars Revenue by Regions 2016-2021 (Million USD)
Table Global Biosimilars Revenue Market Share by Regions 2016-2021
Figure Global Biosimilars Revenue Market Share by Regions in 2020
Table Global Biosimilars Consumption by Regions 2016-2021 (K MT)
Table Global Biosimilars Consumption Market Share by Regions 2016-2021
Figure North America Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure North America Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table North America Biosimilars Production, Consumption Import and Export (K MT)
Figure Europe Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Europe Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Biosimilars Production, Consumption Import and Export (K MT)
Figure China Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure China Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table China Biosimilars Production, Consumption Import and Export (K MT)
Figure Japan Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Japan Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Biosimilars Production, Consumption Import and Export (K MT)
Figure Southeast Asia Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Biosimilars Production, Consumption Import and Export (K MT)
Figure India Biosimilars Production Growth Rate 2016-2021 (K MT)
Figure India Biosimilars Revenue Growth Rate 2016-2021 (Million USD)
Table India Biosimilars Production, Consumption Import and Export (K MT)
Figure Global Consumption Biosimilars Market Share by Application (2016-2021)
Figure Global Value (Consumption) Biosimilars Market Share by Application (2016-2021)
Table Pfizer Biosimilars Production Sites and Area Served
Table Pfizer Biosimilars Product Introduction, Application and Specification
Table Pfizer Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Pfizer Biosimilars Production Growth Rate (2016-2021)
Table Pfizer Biosimilars Production Market Share (2016-2021)
Figure Pfizer Biosimilars Revenue Market Share (2016-2021)
Table Pfizer Biosimilars Main Business and Markets Served
Table Sandoz International GmbH Biosimilars Production Sites and Area Served
Table Sandoz International GmbH Biosimilars Product Introduction, Application and Specification
Table Sandoz International GmbH Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Sandoz International GmbH Biosimilars Production Growth Rate (2016-2021)
Table Sandoz International GmbH Biosimilars Production Market Share (2016-2021)
Figure Sandoz International GmbH Biosimilars Revenue Market Share (2016-2021)
Table Sandoz International GmbH Biosimilars Main Business and Markets Served
Table Teva Pharmaceuticals Industries Biosimilars Production Sites and Area Served
Table Teva Pharmaceuticals Industries Biosimilars Product Introduction, Application and Specification
Table Teva Pharmaceuticals Industries Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Production Growth Rate (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Production Market Share (2016-2021)
Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share (2016-2021)
Table Teva Pharmaceuticals Industries Biosimilars Main Business and Markets Served
Table Amgen Inc Biosimilars Production Sites and Area Served
Table Amgen Inc Biosimilars Product Introduction, Application and Specification
Table Amgen Inc Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Amgen Inc Biosimilars Production Growth Rate (2016-2021)
Table Amgen Inc Biosimilars Production Market Share (2016-2021)
Figure Amgen Inc Biosimilars Revenue Market Share (2016-2021)
Table Amgen Inc Biosimilars Main Business and Markets Served
Table Biocon Biosimilars Production Sites and Area Served
Table Biocon Biosimilars Product Introduction, Application and Specification
Table Biocon Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Biocon Biosimilars Production Growth Rate (2016-2021)
Table Biocon Biosimilars Production Market Share (2016-2021)
Figure Biocon Biosimilars Revenue Market Share (2016-2021)
Table Biocon Biosimilars Main Business and Markets Served
Table Dr. Reddys Laboratories Biosimilars Production Sites and Area Served
Table Dr. Reddys Laboratories Biosimilars Product Introduction, Application and Specification
Table Dr. Reddys Laboratories Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Production Growth Rate (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Production Market Share (2016-2021)
Figure Dr. Reddys Laboratories Biosimilars Revenue Market Share (2016-2021)
Table Dr. Reddys Laboratories Biosimilars Main Business and Markets Served
Table F. Hoffmann-La Roche Biosimilars Production Sites and Area Served
Table F. Hoffmann-La Roche Biosimilars Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Production Growth Rate (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Production Market Share (2016-2021)
Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share (2016-2021)
Table F. Hoffmann-La Roche Biosimilars Main Business and Markets Served
Table Celltrion Biosimilars Production Sites and Area Served
Table Celltrion Biosimilars Product Introduction, Application and Specification
Table Celltrion Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Celltrion Biosimilars Production Growth Rate (2016-2021)
Table Celltrion Biosimilars Production Market Share (2016-2021)
Figure Celltrion Biosimilars Revenue Market Share (2016-2021)
Table Celltrion Biosimilars Main Business and Markets Served
Table Samsung Bioepis Biosimilars Production Sites and Area Served
Table Samsung Bioepis Biosimilars Product Introduction, Application and Specification
Table Samsung Bioepis Biosimilars Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2016-2021)
Table Samsung Bioepis Biosimilars Production Growth Rate (2016-2021)
Table Samsung Bioepis Biosimilars Production Market Share (2016-2021)
Figure Samsung Bioepis Biosimilars Revenue Market Share (2016-2021)
Table Samsung Bioepis Biosimilars Main Business and Markets Served
Figure Global Biosimilars Production (K MT) Growth Rate Forecast 2021-2027
Figure Global Biosimilars Revenue (Million USD) Growth Rate Forecast 2021-2027
Figure Global Biosimilars Sales Price (USD/MT) Forecast 2021-2027
Figure North America Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure North America Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Europe Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Europe Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure China Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure China Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Japan Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Japan Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure Southeast Asia Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Figure India Biosimilars Production Growth Rate Forecast 2021-2027 (K MT)
Figure India Biosimilars Revenue Growth Rate Forecast 2021-2027 (Million USD)
Table Global Production (K MT) of Biosimilars by Type (2021-2027)
Table Global Consumption (K MT) of Biosimilars by Application (2021-2027)
Table Biosimilars Distributors List
Table Biosimilars Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Anti-Allergic Drugs Market

Report Description The Global Anti-Allergic Drugs Market Report provides Insightful information to t

Read More

Cannabis Pharmaceutical Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Can

Read More

Vaccine Packaging Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More